More OncoSil Medical Ltd news
OncoSil Medical LtdASX: OSL

Oncosil breakthrough device receives CE Marking approval

Mar 31, 2020 at 9:50 PM EDT · Issued by OncoSil Medical Ltd

Filed with ASX · Mar 31, 2020 at 9:50 PM EDT

On 6ix: 6ix.com/news/oncosil-breakthrough-device-receives-ce-marking-approval

Oncosil Medical Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

OncoSil Medical Ltd on 6ix

Story so far

  • Update - CE Marking ApplicationMar 29, 2019
  • CE Marking UpdateMar 25, 2019

Earlier from OncoSil Medical

  • Clarification StatementMar 27, 2020
  • Pause in TradingMar 26, 2020
  • FDA Grants Breakthrough Device DesignationMar 17, 2020
  • CE Mark UpdateNov 18, 2019
  • Positive CE Mark Status ReportOct 31, 2019

Later from OncoSil Medical

  • Proposed issue of Securities - OSLMay 3, 2020
  • Allotment of Securities under Institutional PlacementMay 7, 2020
  • OncoSil receives Singapore regulatory approvalMay 31, 2020
  • OncoSil files for TGA registrationJul 1, 2020
  • OncoSil presents clinical data at ESMO World CongressJul 3, 2020
All OncoSil Medical news releases↗

Follow OncoSil Medical into a list and get an email when it puts out news.

Follow OncoSil Medical
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer